Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPRI: Convalescent Plasma for Hospitalized COVID-19 Patients
NCT04421404Phase 2Completed
- Start
- Jun 2020
- Primary completion
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19). Started Jun 2020; status: completed.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04421404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04421404.